6.2.14
Intuition Ek-sentence wali ideaGene therapy kisi bhi disease ko uski genetic root pe fix karti hai — adding, correcting, or silencing genes patient ke cells ke andar — instead of sirf drugs se symptoms treat karne ke.
YEH problem kya solve karti hai?
Kaafi saari diseases (cystic fibrosis, SCID, haemophilia, kuch cancers) ek faulty ya missing gene ki wajah se hoti hain. Conventional drugs sirf downstream consequences ko manage karte hain. Gene therapy cause pe attack karti hai: DNA ko hi.
Ek drug aisa hai jaise leaking pipe ke neeche floor ko hamesha ke liye pochte rehna. Gene therapy pipe ko fix karna hai. Ek acchi repair → "leak" (disease) source pe hi band ho jaata hai.
Har gene therapy ko do independent questions se describe kiya jaata hai:
Definition Axis 1 — KAUN se cells?
Somatic gene therapy: body (non-reproductive) cells ko modify karta hai. Effect patient mein hi rehta hai, inherited nahi hota . (Legal aur widely used.)Germline gene therapy: gametes/embryos ko modify karta hai. Change offspring ko inherit hota hai . (Ethically zyaadatar countries mein humans ke liye banned hai.)
Definition Axis 2 — Editing KAHAN hoti hai?
In vivo : gene carry karne wala vector seedha patient ke body mein deliver kiya jaata hai.Ex vivo : cells ko nikaala jaata hai, lab mein edit kiya jaata hai, check kiya jaata hai, phir patient mein wapas infuse kiya jaata hai.
Koi bhi real therapy ek combination hoti hai, jaise "somatic, ex vivo" (jaisa CAR-T / SCID treatment mein hota hai).
augmentation/addition
Un cells mein gene ki ek working copy add ki jaati hai jisme loss-of-function (recessive) mutation hai. Cell ab missing protein banaata hai. Recessive disorders ke liye kaam karta hai jahan bas protein wapas chahiye.
silencing / knockdown
Ek dominant, toxic gene product ko band kiya jaata hai — RNА interference (siRNA/shRNA) ya CRISPR use karke. Dominant disorders ke liye kaam karta hai jahan bura protein hataana zaroori hai.
editing / correction
Genome mein asli mutation ko precisely rewrite kiya jaata hai (jaise CRISPR-Cas9 + repair template). Native location mein native gene restore karta hai — sabse permanent, precise option.
Intuition Vector kyun chahiyeNaked DNA nucleases se chew ho jaata hai aur efficiently cell membrane cross nahi kar sakta. Humein ek carrier ("vector") chahiye jo DNA ko andar aur nucleus tak smuggle kare.
Viral vectors (retrovirus, lentivirus, adenovirus, AAV): bahut efficient, cells mein enter karne ke liye evolved hain. Risk: immune reaction, aur retroviruses oncogene ke paas insert ho sakte hain → insertional mutagenesis .Non-viral (liposomes/lipid nanoparticles, naked DNA, electroporation): safer, kam immunogenic, lekin lower efficiency .
Vector
Genome mein integrate karta hai?
Consequence
Retrovirus
Haan (dividing cells mein)
Long-lasting, lekin insertion risk
Lentivirus
Haan (non-dividing mein bhi)
Long-lasting
AAV
Zyaadatar episomal
Safer, lekin cells divide hone par dilute hota hai
Liposome
Nahi
Transient, safe
Disease: ADA gene mein mutation → adenosine deaminase nahi → immune cells mar jaate hain.
Step 1: Patient ke bone-marrow stem cells nikaalo. Kyun? → ex vivo se control aur safety checks milte hain.Step 2: Working ADA gene add karne ke liye retro/lentiviral vector use karo. Viral kyun? → stem cells mein high efficiency milti hai.Step 3: Cells wapas infuse karo. Stem cells kyun? → yeh self-renew karte hain, isliye fix persist karta hai jab yeh blood repopulate karte hain.
Classification: somatic + ex vivo + gene augmentation .
Lung epithelium mein faulty CFTR chloride channel.
Working CFTR gene ko liposome aerosol / inhaled AAV ke zariye seedha lungs tak deliver karo. In vivo kyun? → lung lining cells ko nikaal nahi sakte.
Classification: somatic + in vivo + gene augmentation . Challenge: lung cells turn over karte hain, isliye yeh repeat karna padta hai.
Ek dominant toxic mutant huntingtin protein ki wajah se hota hai.
Sirf acchi copy add nahi kar sakte (buri copy phir bhi poison karti rahegi). Kyun? → dominant hai. Isliye gene silencing use karo (mutant allele ka siRNA/CRISPR knockdown).
Classification: somatic + in vivo + gene silencing .
Common mistake Steel-manned misconceptions"Gene therapy hamesha permanently cure karti hai."
Yeh sahi kyun lagta hai: DNA change kiya, toh surely hamesha ke liye. Fix: agar vector episomal (AAV, liposome) hai ya non-dividing / short-lived cells (lung lining) ko target karta hai, toh gene dilute ya lost ho jaata hai → repeat doses chahiye. Permanence ke liye genome integration ya stem-cell targeting chahiye.
"Acchi gene add karna koi bhi disease fix kar deta hai."
Yeh sahi kyun lagta hai: accha protein wapas aa jaata hai. Fix: sirf recessive/loss-of-function disorders ke liye kaam karta hai. Dominant toxic-protein diseases ke liye silence ya edit karna padta hai, add nahi.
"Somatic therapy bachon ko pass ho sakti hai."
Yeh sahi kyun lagta hai: DNA change hua tha. Fix: sirf germline (gametes/embryos) heritable hota hai; somatic cells germline mein nahi hote.
"Viral vectors sirf dangerous hain, inhe avoid karo."
Yeh sahi kyun lagta hai: "virus" bura lagta hai. Fix: yeh disabled hote hain (replication genes remove kar diye jaate hain). Trade-off efficiency vs. immune/insertion risk ka hai, disease ka nahi.
Recall Feynman: 12-year-old ko explain karoTumhara body ek instruction book (DNA) follow karta hai. Kabhi kabhi ek page pe typo hoti hai jo tumhe beemaar karti hai. Gene therapy aisa hai jaise:
(1) page ki acchi copy tape kar dena (add ), (2) ek bure page ko cross out kar dena jo galat orders deta hai (silence ), ya (3) exact typo fix karne ke liye tiny scissors use karna (edit ). Nayi page carry karne ke liye hum ek delivery van use karte hain — kabhi ek tamed virus (fast) ya ek tiny fat bubble (safe). Agar hum un cells ko fix karte hain jo apni copies banate rehte hain, toh fix lamba chalta hai.
"SIGE, in the SEED"
S ilence, A ugment, E dit → 3 strategies (SAE).SE-ED : S omatic/germline, E x/in vivo, E fficiency vs. safety (vector), D elivery.
Aur: "AAV Avoids integrating; Retro Really integrates."
Somatic gene therapy — inherited hoti hai ya nahi? Inherited nahi hoti; sirf body cells modify hote hain, gametes nahi.
Germline gene therapy kya alter karta hai, aur yeh banned kyun hai? Gametes/embryos — change heritable hota hai; humans mein ethical/safety reasons se banned hai.
In vivo aur ex vivo gene therapy mein kya fark hai? In vivo = vector seedha patient mein deliver hota hai; ex vivo = cells nikale jaate hain, lab mein edit hote hain, phir re-infuse hote hain.
Recessive loss-of-function disease ke liye kaun si strategy suit karti hai? Gene augmentation (working copy add karo).
Dominant toxic-protein disease ke liye kaun si strategy suit karti hai? Gene silencing/knockdown (ya mutant allele disrupt karne ke liye editing).
Gene editing (augmentation se alag) kya hai? Native locus par actual mutation ki precise rewriting (jaise CRISPR-Cas9 + repair template).
Risks ke bawajood viral vectors kyun use karte hain? Yeh efficiently cells mein enter karne ke liye evolve hue hain → high delivery/expression.
Retroviral vectors ka main risk kya hai? Insertional mutagenesis (random integration ek oncogene activate kar sakta hai).
AAV therapy ko baar baar dose kyun chahiye hota hai? Yeh episomal rehta hai, isliye cells divide hone par dilute/lost ho jaata hai.
SCID therapy mein stem cells ko target kyun karte hain? Yeh self-renew karte hain, isliye corrected gene persist karta hai jab yeh blood repopulate karte hain.
Cystic fibrosis in vivo treat kyun hoti hai? Lung epithelium nikaal/re-infuse nahi kar sakte; seedha deliver karo (aerosol AAV/liposome).
Liposome (non-viral) vectors ka advantage aur drawback kya hai? Advantage: safe/low immunogenicity; drawback: low efficiency, transient.
CRISPR-Cas9 mechanism — gene editing ke liye molecular toolViral vectors and vector design Recombinant DNA technology — working gene copy kaise banti haiSCID and CAR-T cell therapy — ex vivo somatic examplesDominant vs recessive inheritance — decide karta hai augment vs silenceRNA interference (siRNA/shRNA) — silencing mechanismEthics of germline editing
